MassiveID	filename	SampleName	SampleType	NCBITaxonomy	UBERONBodyPartName	HealthStatus	DOIDCommonName	YearOfAnalysis	SampleCollectionMethod	Country	YearOfAnalysis.1	MassSpectrometer	IonizationSourceAndPolarity	ChromatographyAndPhase	UniqueSubjectID	Month	LifeStage	BiologicalSex	AgeInYears	atcd_pseu_aeru	muco_mutation	muco_insuf_pancreat	Exacerbationstatus	Kaftrio	SampleExtractionMethod	InternalStandardsUsed
MSV000100923	1M0.mzXML	1M0	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002722	electrospray ionization (positive)	reverse phase (C18)	1.0	0.0	Early Adulthood (18 yrs < x <= 45 yrs)	1.0	26.0	1.0	DF508/DF508	0.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d5 
MSV000100923	1M3.mzXML	1M3	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002751	electrospray ionization (positive)	reverse phase (C18)	1.0	3.0	Early Adulthood (18 yrs < x <= 45 yrs)	1.0	26.0	1.0	DF508/DF508	0.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d6
MSV000100923	1M6.mzXML	1M6	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002692	electrospray ionization (positive)	reverse phase (C18)	1.0	6.0	Early Adulthood (18 yrs < x <= 45 yrs)	1.0	26.0	1.0	DF508/DF508	0.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d7
MSV000100923	1M9.mzXML	1M9	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002686	electrospray ionization (positive)	reverse phase (C18)	1.0	9.0	Early Adulthood (18 yrs < x <= 45 yrs)	1.0	26.0	1.0	DF508/DF508	0.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d8
MSV000100923	1M15.mzXML	1M15	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002674	electrospray ionization (positive)	reverse phase (C18)	1.0	15.0	Early Adulthood (18 yrs < x <= 45 yrs)	1.0	26.0	1.0	DF508/DF508	0.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d9
MSV000100923	1M18.mzXML	1M18	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002726	electrospray ionization (positive)	reverse phase (C18)	1.0	18.0	Early Adulthood (18 yrs < x <= 45 yrs)	1.0	26.0	1.0	DF508/DF508	0.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d10
MSV000100923	2M0.mzXML	2M0	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002652	electrospray ionization (positive)	reverse phase (C18)	2.0	0.0	Early Adulthood (18 yrs < x <= 45 yrs)	2.0	34.0	1.0	DF508	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d11
MSV000100923	2M3.mzXML	2M3	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002697	electrospray ionization (positive)	reverse phase (C18)	2.0	3.0	Early Adulthood (18 yrs < x <= 45 yrs)	2.0	34.0	1.0	DF508	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d12
MSV000100923	2M9.mzXML	2M9	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002664	electrospray ionization (positive)	reverse phase (C18)	2.0	9.0	Early Adulthood (18 yrs < x <= 45 yrs)	2.0	34.0	1.0	DF508	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d13
MSV000100923	2M15.mzXML	2M15	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002744	electrospray ionization (positive)	reverse phase (C18)	2.0	15.0	Early Adulthood (18 yrs < x <= 45 yrs)	2.0	34.0	1.0	DF508	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d14
MSV000100923	2M18.mzXML	2M18	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002655	electrospray ionization (positive)	reverse phase (C18)	2.0	18.0	Early Adulthood (18 yrs < x <= 45 yrs)	2.0	34.0	1.0	DF508	1.0	Exa	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d15
MSV000100923	3M0.mzXML	3M0	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002783	electrospray ionization (positive)	reverse phase (C18)	3.0	0.0	Early Adulthood (18 yrs < x <= 45 yrs)	3.0	38.0	1.0	DF508/N13	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d16
MSV000100923	3M18.mzXML	3M18	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002747	electrospray ionization (positive)	reverse phase (C18)	3.0	18.0	Early Adulthood (18 yrs < x <= 45 yrs)	3.0	38.0	1.0	DF508/N13	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d17
MSV000100923	5M0.mzXML	5M0	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002670	electrospray ionization (positive)	reverse phase (C18)	5.0	0.0	Early Adulthood (18 yrs < x <= 45 yrs)	5.0	27.0	1.0	DF508/R334W	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d18
MSV000100923	5M6.mzXML	5M6	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002653	electrospray ionization (positive)	reverse phase (C18)	5.0	6.0	Early Adulthood (18 yrs < x <= 45 yrs)	5.0	27.0	1.0	DF508/R334W	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d19
MSV000100923	5M9.mzXML	5M9	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002753	electrospray ionization (positive)	reverse phase (C18)	5.0	9.0	Early Adulthood (18 yrs < x <= 45 yrs)	5.0	27.0	1.0	DF508/R334W	1.0	Exa	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d20
MSV000100923	5M18.mzXML	5M18	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002721	electrospray ionization (positive)	reverse phase (C18)	5.0	18.0	Early Adulthood (18 yrs < x <= 45 yrs)	5.0	27.0	1.0	DF508/R334W	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d21
MSV000100923	6M0.mzXML	6M0	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002690	electrospray ionization (positive)	reverse phase (C18)	6.0	0.0	Early Adulthood (18 yrs < x <= 45 yrs)	6.0	24.0	0.0	DF508/DF508	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d22
MSV000100923	6M3.mzXML	6M3	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002741	electrospray ionization (positive)	reverse phase (C18)	6.0	3.0	Early Adulthood (18 yrs < x <= 45 yrs)	6.0	24.0	0.0	DF508/DF508	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d23
MSV000100923	6M6.mzXML	6M6	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002740	electrospray ionization (positive)	reverse phase (C18)	6.0	6.0	Early Adulthood (18 yrs < x <= 45 yrs)	6.0	24.0	0.0	DF508/DF508	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d24
MSV000100923	6M12.mzXML	6M12	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002771	electrospray ionization (positive)	reverse phase (C18)	6.0	12.0	Early Adulthood (18 yrs < x <= 45 yrs)	6.0	24.0	0.0	DF508/DF508	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d25
MSV000100923	6M18.mzXML	6M18	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002665	electrospray ionization (positive)	reverse phase (C18)	6.0	18.0	Early Adulthood (18 yrs < x <= 45 yrs)	6.0	24.0	0.0	DF508/DF508	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d26
MSV000100923	7M3.mzXML	7M3	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002786	electrospray ionization (positive)	reverse phase (C18)	7.0	3.0	Adolescence (8 yrs < x <= 18 yrs)	7.0	13.0	1.0	711+1 G>T/711+1G>T	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d27
MSV000100923	7M6.mzXML	7M6	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002737	electrospray ionization (positive)	reverse phase (C18)	7.0	6.0	Adolescence (8 yrs < x <= 18 yrs)	7.0	13.0	1.0	711+1 G>T/711+1G>T	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d28
MSV000100923	7M12.mzXML	7M12	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002732	electrospray ionization (positive)	reverse phase (C18)	7.0	12.0	Adolescence (8 yrs < x <= 18 yrs)	7.0	13.0	1.0	711+1 G>T/711+1G>T	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d29
MSV000100923	8M0.mzXML	8M0	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002661	electrospray ionization (positive)	reverse phase (C18)	8.0	0.0	Early Adulthood (18 yrs < x <= 45 yrs)	8.0	33.0	1.0	DF508	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d30
MSV000100923	8M3.mzXML	8M3	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002694	electrospray ionization (positive)	reverse phase (C18)	8.0	3.0	Early Adulthood (18 yrs < x <= 45 yrs)	8.0	33.0	1.0	DF508	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d31
MSV000100923	8M9.mzXML	8M9	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002679	electrospray ionization (positive)	reverse phase (C18)	8.0	9.0	Early Adulthood (18 yrs < x <= 45 yrs)	8.0	33.0	1.0	DF508	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d32
MSV000100923	8M12.mzXML	8M12	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002666	electrospray ionization (positive)	reverse phase (C18)	8.0	12.0	Early Adulthood (18 yrs < x <= 45 yrs)	8.0	33.0	1.0	DF508	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d33
MSV000100923	8M15.mzXML	8M15	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002650	electrospray ionization (positive)	reverse phase (C18)	8.0	15.0	Early Adulthood (18 yrs < x <= 45 yrs)	8.0	33.0	1.0	DF508	1.0	No	Kaftrio	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d34
MSV000100923	8M18.mzXML	8M18	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002659	electrospray ionization (positive)	reverse phase (C18)	8.0	18.0	Early Adulthood (18 yrs < x <= 45 yrs)	8.0	33.0	1.0	DF508	1.0	No	Kaftrio	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d35
MSV000100923	9M3.mzXML	9M3	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002774	electrospray ionization (positive)	reverse phase (C18)	9.0	3.0	Early Adulthood (18 yrs < x <= 45 yrs)	9.0	39.0	1.0	DF508/CFTRdup10-18	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d36
MSV000100923	9M6.mzXML	9M6	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002706	electrospray ionization (positive)	reverse phase (C18)	9.0	6.0	Early Adulthood (18 yrs < x <= 45 yrs)	9.0	39.0	1.0	DF508/CFTRdup10-18	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d37
MSV000100923	9M12.mzXML	9M12	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002742	electrospray ionization (positive)	reverse phase (C18)	9.0	12.0	Early Adulthood (18 yrs < x <= 45 yrs)	9.0	39.0	1.0	DF508/CFTRdup10-18	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d38
MSV000100923	9M15.mzXML	9M15	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002711	electrospray ionization (positive)	reverse phase (C18)	9.0	15.0	Early Adulthood (18 yrs < x <= 45 yrs)	9.0	39.0	1.0	DF508/CFTRdup10-18	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d39
MSV000100923	9M18.mzXML	9M18	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002681	electrospray ionization (positive)	reverse phase (C18)	9.0	18.0	Early Adulthood (18 yrs < x <= 45 yrs)	9.0	39.0	1.0	DF508/CFTRdup10-18	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d40
MSV000100923	10M0.mzXML	10M0	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002695	electrospray ionization (positive)	reverse phase (C18)	10.0	0.0	Early Adulthood (18 yrs < x <= 45 yrs)	10.0	19.0	1.0	DF508/DF508	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d41
MSV000100923	10M6.mzXML	10M6	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002743	electrospray ionization (positive)	reverse phase (C18)	10.0	6.0	Early Adulthood (18 yrs < x <= 45 yrs)	10.0	19.0	1.0	DF508/DF508	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d42
MSV000100923	10M12.mzXML	10M12	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002702	electrospray ionization (positive)	reverse phase (C18)	10.0	12.0	Early Adulthood (18 yrs < x <= 45 yrs)	10.0	19.0	1.0	DF508/DF508	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d43
MSV000100923	10M15.mzXML	10M15	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002715	electrospray ionization (positive)	reverse phase (C18)	10.0	15.0	Early Adulthood (18 yrs < x <= 45 yrs)	10.0	19.0	1.0	DF508/DF508	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d44
MSV000100923	10M18.mzXML	10M18	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002680	electrospray ionization (positive)	reverse phase (C18)	10.0	18.0	Early Adulthood (18 yrs < x <= 45 yrs)	10.0	19.0	1.0	DF508/DF508	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d45
MSV000100923	12M0.mzXML	12M0	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002780	electrospray ionization (positive)	reverse phase (C18)	12.0	0.0	Early Adulthood (18 yrs < x <= 45 yrs)	12.0	19.0	0.0	DF508/G542X	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d46
MSV000100923	12M6.mzXML	12M6	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002685	electrospray ionization (positive)	reverse phase (C18)	12.0	6.0	Early Adulthood (18 yrs < x <= 45 yrs)	12.0	19.0	0.0	DF508/G542X	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d47
MSV000100923	12M9.mzXML	12M9	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002757	electrospray ionization (positive)	reverse phase (C18)	12.0	9.0	Early Adulthood (18 yrs < x <= 45 yrs)	12.0	19.0	0.0	DF508/G542X	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d48
MSV000100923	12M12.mzXML	12M12	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002784	electrospray ionization (positive)	reverse phase (C18)	12.0	12.0	Early Adulthood (18 yrs < x <= 45 yrs)	12.0	19.0	0.0	DF508/G542X	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d49
MSV000100923	12M15.mzXML	12M15	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002730	electrospray ionization (positive)	reverse phase (C18)	12.0	15.0	Early Adulthood (18 yrs < x <= 45 yrs)	12.0	19.0	0.0	DF508/G542X	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d50
MSV000100923	12M18.mzXML	12M18	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002727	electrospray ionization (positive)	reverse phase (C18)	12.0	18.0	Early Adulthood (18 yrs < x <= 45 yrs)	12.0	19.0	0.0	DF508/G542X	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d51
MSV000100923	13M0.mzXML	13M0	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002657	electrospray ionization (positive)	reverse phase (C18)	13.0	0.0	Early Adulthood (18 yrs < x <= 45 yrs)	13.0	24.0	1.0	DF508/3007delG	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d52
MSV000100923	13M3.mzXML	13M3	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002712	electrospray ionization (positive)	reverse phase (C18)	13.0	3.0	Early Adulthood (18 yrs < x <= 45 yrs)	13.0	24.0	1.0	DF508/3007delG	1.0	No	Kaftrio	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d53
MSV000100923	13M6.mzXML	13M6	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002746	electrospray ionization (positive)	reverse phase (C18)	13.0	6.0	Early Adulthood (18 yrs < x <= 45 yrs)	13.0	24.0	1.0	DF508/3007delG	1.0	No	Kaftrio	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d54
MSV000100923	13M9.mzXML	13M9	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002663	electrospray ionization (positive)	reverse phase (C18)	13.0	9.0	Early Adulthood (18 yrs < x <= 45 yrs)	13.0	24.0	1.0	DF508/3007delG	1.0	No	Kaftrio	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d55
MSV000100923	13M12.mzXML	13M12	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002671	electrospray ionization (positive)	reverse phase (C18)	13.0	12.0	Early Adulthood (18 yrs < x <= 45 yrs)	13.0	24.0	1.0	DF508/3007delG	1.0	No	Kaftrio	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d56
MSV000100923	13M18.mzXML	13M18	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002749	electrospray ionization (positive)	reverse phase (C18)	13.0	18.0	Early Adulthood (18 yrs < x <= 45 yrs)	13.0	24.0	1.0	DF508/3007delG	1.0	No	Kaftrio	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d57
MSV000100923	14M0.mzXML	14M0	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002684	electrospray ionization (positive)	reverse phase (C18)	14.0	0.0	Early Adulthood (18 yrs < x <= 45 yrs)	14.0	25.0	0.0	DF508/DF508	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d58
MSV000100923	14M3.mzXML	14M3	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002733	electrospray ionization (positive)	reverse phase (C18)	14.0	3.0	Early Adulthood (18 yrs < x <= 45 yrs)	14.0	25.0	0.0	DF508/DF508	1.0	Exa	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d59
MSV000100923	14M6.mzXML	14M6	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002765	electrospray ionization (positive)	reverse phase (C18)	14.0	6.0	Early Adulthood (18 yrs < x <= 45 yrs)	14.0	25.0	0.0	DF508/DF508	1.0	Exa	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d60
MSV000100923	14M9.mzXML	14M9	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002770	electrospray ionization (positive)	reverse phase (C18)	14.0	9.0	Early Adulthood (18 yrs < x <= 45 yrs)	14.0	25.0	0.0	DF508/DF508	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d61
MSV000100923	14M12.mzXML	14M12	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002759	electrospray ionization (positive)	reverse phase (C18)	14.0	12.0	Early Adulthood (18 yrs < x <= 45 yrs)	14.0	25.0	0.0	DF508/DF508	1.0	Exa	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d62
MSV000100923	14M15.mzXML	14M15	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002760	electrospray ionization (positive)	reverse phase (C18)	14.0	15.0	Early Adulthood (18 yrs < x <= 45 yrs)	14.0	25.0	0.0	DF508/DF508	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d63
MSV000100923	14M18.mzXML	14M18	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002734	electrospray ionization (positive)	reverse phase (C18)	14.0	18.0	Early Adulthood (18 yrs < x <= 45 yrs)	14.0	25.0	0.0	DF508/DF508	1.0	No	Kaftrio	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d64
MSV000100923	15M0.mzXML	15M0	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002682	electrospray ionization (positive)	reverse phase (C18)	15.0	0.0	Early Adulthood (18 yrs < x <= 45 yrs)	15.0	30.0	1.0	DF508/W1282X	0.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d65
MSV000100923	15M3.mzXML	15M3	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002756	electrospray ionization (positive)	reverse phase (C18)	15.0	3.0	Early Adulthood (18 yrs < x <= 45 yrs)	15.0	30.0	1.0	DF508/W1282X	0.0	Exa	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d66
MSV000100923	15M6.mzXML	15M6	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002707	electrospray ionization (positive)	reverse phase (C18)	15.0	6.0	Early Adulthood (18 yrs < x <= 45 yrs)	15.0	30.0	1.0	DF508/W1282X	0.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d67
MSV000100923	15M9.mzXML	15M9	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002699	electrospray ionization (positive)	reverse phase (C18)	15.0	9.0	Early Adulthood (18 yrs < x <= 45 yrs)	15.0	30.0	1.0	DF508/W1282X	0.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d68
MSV000100923	15M12.mzXML	15M12	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002731	electrospray ionization (positive)	reverse phase (C18)	15.0	12.0	Early Adulthood (18 yrs < x <= 45 yrs)	15.0	30.0	1.0	DF508/W1282X	0.0	No	Kaftrio	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d69
MSV000100923	15M15.mzXML	15M15	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002673	electrospray ionization (positive)	reverse phase (C18)	15.0	15.0	Early Adulthood (18 yrs < x <= 45 yrs)	15.0	30.0	1.0	DF508/W1282X	0.0	No	Kaftrio	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d70
MSV000100923	15M18.mzXML	15M18	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002785	electrospray ionization (positive)	reverse phase (C18)	15.0	18.0	Early Adulthood (18 yrs < x <= 45 yrs)	15.0	30.0	1.0	DF508/W1282X	0.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d71
MSV000100923	16M0.mzXML	16M0	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002675	electrospray ionization (positive)	reverse phase (C18)	16.0	0.0	Early Adulthood (18 yrs < x <= 45 yrs)	16.0	19.0	1.0	DF505/DF508	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d72
MSV000100923	16M3.mzXML	16M3	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002754	electrospray ionization (positive)	reverse phase (C18)	16.0	3.0	Early Adulthood (18 yrs < x <= 45 yrs)	16.0	19.0	1.0	DF505/DF508	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d73
MSV000100923	16M9.mzXML	16M9	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002755	electrospray ionization (positive)	reverse phase (C18)	16.0	9.0	Early Adulthood (18 yrs < x <= 45 yrs)	16.0	19.0	1.0	DF505/DF508	1.0	Exa	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d74
MSV000100923	16M12.mzXML	16M12	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002725	electrospray ionization (positive)	reverse phase (C18)	16.0	12.0	Early Adulthood (18 yrs < x <= 45 yrs)	16.0	19.0	1.0	DF505/DF508	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d75
MSV000100923	16M15.mzXML	16M15	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002691	electrospray ionization (positive)	reverse phase (C18)	16.0	15.0	Early Adulthood (18 yrs < x <= 45 yrs)	16.0	19.0	1.0	DF505/DF508	1.0	Exa	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d76
MSV000100923	16M18.mzXML	16M18	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002700	electrospray ionization (positive)	reverse phase (C18)	16.0	18.0	Early Adulthood (18 yrs < x <= 45 yrs)	16.0	19.0	1.0	DF505/DF508	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d77
MSV000100923	17M0.mzXML	17M0	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002714	electrospray ionization (positive)	reverse phase (C18)	17.0	0.0	Early Adulthood (18 yrs < x <= 45 yrs)	17.0	23.0	1.0	DF508/DF508	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d78
MSV000100923	17M3.mzXML	17M3	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002689	electrospray ionization (positive)	reverse phase (C18)	17.0	3.0	Early Adulthood (18 yrs < x <= 45 yrs)	17.0	23.0	1.0	DF508/DF508	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d79
MSV000100923	17M6.mzXML	17M6	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002669	electrospray ionization (positive)	reverse phase (C18)	17.0	6.0	Early Adulthood (18 yrs < x <= 45 yrs)	17.0	23.0	1.0	DF508/DF508	1.0	No	Kaftrio	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d80
MSV000100923	17M9.mzXML	17M9	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002654	electrospray ionization (positive)	reverse phase (C18)	17.0	9.0	Early Adulthood (18 yrs < x <= 45 yrs)	17.0	23.0	1.0	DF508/DF508	1.0	No	Kaftrio	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d81
MSV000100923	17M12.mzXML	17M12	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002719	electrospray ionization (positive)	reverse phase (C18)	17.0	12.0	Early Adulthood (18 yrs < x <= 45 yrs)	17.0	23.0	1.0	DF508/DF508	1.0	No	Kaftrio	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d82
MSV000100923	17M15.mzXML	17M15	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002720	electrospray ionization (positive)	reverse phase (C18)	17.0	15.0	Early Adulthood (18 yrs < x <= 45 yrs)	17.0	23.0	1.0	DF508/DF508	1.0	No	Kaftrio	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d83
MSV000100923	17M18.mzXML	17M18	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002752	electrospray ionization (positive)	reverse phase (C18)	17.0	18.0	Early Adulthood (18 yrs < x <= 45 yrs)	17.0	23.0	1.0	DF508/DF508	1.0	No	Kaftrio	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d84
MSV000100923	18M0.mzXML	18M0	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002766	electrospray ionization (positive)	reverse phase (C18)	18.0	0.0	Early Adulthood (18 yrs < x <= 45 yrs)	18.0	34.0	1.0	DF508/DF508	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d85
MSV000100923	18M3.mzXML	18M3	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002736	electrospray ionization (positive)	reverse phase (C18)	18.0	3.0	Early Adulthood (18 yrs < x <= 45 yrs)	18.0	34.0	1.0	DF508/DF508	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d86
MSV000100923	18M6.mzXML	18M6	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002775	electrospray ionization (positive)	reverse phase (C18)	18.0	6.0	Early Adulthood (18 yrs < x <= 45 yrs)	18.0	34.0	1.0	DF508/DF508	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d87
MSV000100923	18M9.mzXML	18M9	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002787	electrospray ionization (positive)	reverse phase (C18)	18.0	9.0	Early Adulthood (18 yrs < x <= 45 yrs)	18.0	34.0	1.0	DF508/DF508	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d88
MSV000100923	18M15.mzXML	18M15	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002745	electrospray ionization (positive)	reverse phase (C18)	18.0	15.0	Early Adulthood (18 yrs < x <= 45 yrs)	18.0	34.0	1.0	DF508/DF508	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d89
MSV000100923	18M18.mzXML	18M18	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002723	electrospray ionization (positive)	reverse phase (C18)	18.0	18.0	Early Adulthood (18 yrs < x <= 45 yrs)	18.0	34.0	1.0	DF508/DF508	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d90
MSV000100923	19M0.mzXML	19M0	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002687	electrospray ionization (positive)	reverse phase (C18)	19.0	0.0	Adolescence (8 yrs < x <= 18 yrs)	19.0	17.0	1.0	DF508/1811+1,6kbA>G	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d91
MSV000100923	19M3.mzXML	19M3	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002724	electrospray ionization (positive)	reverse phase (C18)	19.0	3.0	Adolescence (8 yrs < x <= 18 yrs)	19.0	17.0	1.0	DF508/1811+1,6kbA>G	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d92
MSV000100923	19M6.mzXML	19M6	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002769	electrospray ionization (positive)	reverse phase (C18)	19.0	6.0	Adolescence (8 yrs < x <= 18 yrs)	19.0	17.0	1.0	DF508/1811+1,6kbA>G	1.0	No	Kaftrio	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d93
MSV000100923	19M12.mzXML	19M12	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002717	electrospray ionization (positive)	reverse phase (C18)	19.0	12.0	Adolescence (8 yrs < x <= 18 yrs)	19.0	17.0	1.0	DF508/1811+1,6kbA>G	1.0	No	Kaftrio	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d94
MSV000100923	19M15.mzXML	19M15	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002696	electrospray ionization (positive)	reverse phase (C18)	19.0	15.0	Adolescence (8 yrs < x <= 18 yrs)	19.0	17.0	1.0	DF508/1811+1,6kbA>G	1.0	No	Kaftrio	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d95
MSV000100923	20M0.mzXML	20M0	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002779	electrospray ionization (positive)	reverse phase (C18)	20.0	0.0	Middle Adulthood (45 yrs < x <= 65 yrs)	20.0	51.0	0.0	DF508/V232D	0.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d96
MSV000100923	20M3.mzXML	20M3	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	20.0	3.0	Middle Adulthood (45 yrs < x <= 65 yrs)	20.0	51.0	0.0	DF508/V232D	0.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d97
MSV000100923	20M9.mzXML	20M9	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002703	electrospray ionization (positive)	reverse phase (C18)	20.0	9.0	Middle Adulthood (45 yrs < x <= 65 yrs)	20.0	51.0	0.0	DF508/V232D	0.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d98
MSV000100923	20M15.mzXML	20M15	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002693	electrospray ionization (positive)	reverse phase (C18)	20.0	15.0	Middle Adulthood (45 yrs < x <= 65 yrs)	20.0	51.0	0.0	DF508/V232D	0.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d99
MSV000100923	20M18.mzXML	20M18	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002716	electrospray ionization (positive)	reverse phase (C18)	20.0	18.0	Middle Adulthood (45 yrs < x <= 65 yrs)	20.0	51.0	0.0	DF508/V232D	0.0	No	Kaftrio	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d100
MSV000100923	21M0.mzXML	21M0	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002772	electrospray ionization (positive)	reverse phase (C18)	21.0	0.0	Middle Adulthood (45 yrs < x <= 65 yrs)	21.0	49.0	0.0	2118Del4/S902R	0.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d101
MSV000100923	21M3.mzXML	21M3	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002777	electrospray ionization (positive)	reverse phase (C18)	21.0	3.0	Middle Adulthood (45 yrs < x <= 65 yrs)	21.0	49.0	0.0	2118Del4/S902R	0.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d102
MSV000100923	21M6.mzXML	21M6	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002739	electrospray ionization (positive)	reverse phase (C18)	21.0	6.0	Middle Adulthood (45 yrs < x <= 65 yrs)	21.0	49.0	0.0	2118Del4/S902R	0.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d103
MSV000100923	21M12.mzXML	21M12	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002649	electrospray ionization (positive)	reverse phase (C18)	21.0	12.0	Middle Adulthood (45 yrs < x <= 65 yrs)	21.0	49.0	0.0	2118Del4/S902R	0.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d104
MSV000100923	21M18.mzXML	21M18	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002709	electrospray ionization (positive)	reverse phase (C18)	21.0	18.0	Middle Adulthood (45 yrs < x <= 65 yrs)	21.0	49.0	0.0	2118Del4/S902R	0.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d105
MSV000100923	22M0.mzXML	22M0	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002660	electrospray ionization (positive)	reverse phase (C18)	22.0	0.0	Early Adulthood (18 yrs < x <= 45 yrs)	22.0	21.0	0.0	DI507/E585X	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d106
MSV000100923	22M3.mzXML	22M3	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002656	electrospray ionization (positive)	reverse phase (C18)	22.0	3.0	Early Adulthood (18 yrs < x <= 45 yrs)	22.0	21.0	0.0	DI507/E585X	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d107
MSV000100923	22M6.mzXML	22M6	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002735	electrospray ionization (positive)	reverse phase (C18)	22.0	6.0	Early Adulthood (18 yrs < x <= 45 yrs)	22.0	21.0	0.0	DI507/E585X	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d108
MSV000100923	22M9.mzXML	22M9	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002763	electrospray ionization (positive)	reverse phase (C18)	22.0	9.0	Early Adulthood (18 yrs < x <= 45 yrs)	22.0	21.0	0.0	DI507/E585X	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d109
MSV000100923	22M12.mzXML	22M12	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002776	electrospray ionization (positive)	reverse phase (C18)	22.0	12.0	Early Adulthood (18 yrs < x <= 45 yrs)	22.0	21.0	0.0	DI507/E585X	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d110
MSV000100923	22M15.mzXML	22M15	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002672	electrospray ionization (positive)	reverse phase (C18)	22.0	15.0	Early Adulthood (18 yrs < x <= 45 yrs)	22.0	21.0	0.0	DI507/E585X	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d111
MSV000100923	22M18.mzXML	22M18	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002773	electrospray ionization (positive)	reverse phase (C18)	22.0	18.0	Early Adulthood (18 yrs < x <= 45 yrs)	22.0	21.0	0.0	DI507/E585X	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d112
MSV000100923	23M0.mzXML	23M0	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002676	electrospray ionization (positive)	reverse phase (C18)	23.0	0.0	Early Adulthood (18 yrs < x <= 45 yrs)	23.0	45.0	1.0	DF508/A455E	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d113
MSV000100923	23M3.mzXML	23M3	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002677	electrospray ionization (positive)	reverse phase (C18)	23.0	3.0	Early Adulthood (18 yrs < x <= 45 yrs)	23.0	45.0	1.0	DF508/A455E	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d114
MSV000100923	23M6.mzXML	23M6	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002704	electrospray ionization (positive)	reverse phase (C18)	23.0	6.0	Early Adulthood (18 yrs < x <= 45 yrs)	23.0	45.0	1.0	DF508/A455E	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d115
MSV000100923	23M9.mzXML	23M9	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002764	electrospray ionization (positive)	reverse phase (C18)	23.0	9.0	Early Adulthood (18 yrs < x <= 45 yrs)	23.0	45.0	1.0	DF508/A455E	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d116
MSV000100923	23M15.mzXML	23M15	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002683	electrospray ionization (positive)	reverse phase (C18)	23.0	15.0	Early Adulthood (18 yrs < x <= 45 yrs)	23.0	45.0	1.0	DF508/A455E	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d117
MSV000100923	23M18.mzXML	23M18	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002710	electrospray ionization (positive)	reverse phase (C18)	23.0	18.0	Early Adulthood (18 yrs < x <= 45 yrs)	23.0	45.0	1.0	DF508/A455E	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d118
MSV000100923	24M0.mzXML	24M0	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002662	electrospray ionization (positive)	reverse phase (C18)	24.0	0.0	Adolescence (8 yrs < x <= 18 yrs)	24.0	16.0	0.0	DF508/DF508	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d119
MSV000100923	24M3.mzXML	24M3	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002701	electrospray ionization (positive)	reverse phase (C18)	24.0	3.0	Adolescence (8 yrs < x <= 18 yrs)	24.0	16.0	0.0	DF508/DF508	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d120
MSV000100923	24M9.mzXML	24M9	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002713	electrospray ionization (positive)	reverse phase (C18)	24.0	9.0	Adolescence (8 yrs < x <= 18 yrs)	24.0	16.0	0.0	DF508/DF508	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d121
MSV000100923	24M12.mzXML	24M12	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002782	electrospray ionization (positive)	reverse phase (C18)	24.0	12.0	Adolescence (8 yrs < x <= 18 yrs)	24.0	16.0	0.0	DF508/DF508	1.0	No	Kaftrio	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d122
MSV000100923	24M15.mzXML	24M15	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002729	electrospray ionization (positive)	reverse phase (C18)	24.0	15.0	Adolescence (8 yrs < x <= 18 yrs)	24.0	16.0	0.0	DF508/DF508	1.0	No	Kaftrio	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d123
MSV000100923	25M0.mzXML	25M0	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002762	electrospray ionization (positive)	reverse phase (C18)	25.0	0.0	Early Adulthood (18 yrs < x <= 45 yrs)	25.0	36.0	1.0	DF508/DF508	1.0	Exa	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d124
MSV000100923	25M3.mzXML	25M3	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002651	electrospray ionization (positive)	reverse phase (C18)	25.0	3.0	Early Adulthood (18 yrs < x <= 45 yrs)	25.0	36.0	1.0	DF508/DF508	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d125
MSV000100923	25M6.mzXML	25M6	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002761	electrospray ionization (positive)	reverse phase (C18)	25.0	6.0	Early Adulthood (18 yrs < x <= 45 yrs)	25.0	36.0	1.0	DF508/DF508	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d126
MSV000100923	25M9.mzXML	25M9	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002750	electrospray ionization (positive)	reverse phase (C18)	25.0	9.0	Early Adulthood (18 yrs < x <= 45 yrs)	25.0	36.0	1.0	DF508/DF508	1.0	Exa	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d127
MSV000100923	25M12.mzXML	25M12	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002781	electrospray ionization (positive)	reverse phase (C18)	25.0	12.0	Early Adulthood (18 yrs < x <= 45 yrs)	25.0	36.0	1.0	DF508/DF508	1.0	No	No	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d128
MSV000100923	25M15.mzXML	25M15	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002705	electrospray ionization (positive)	reverse phase (C18)	25.0	15.0	Early Adulthood (18 yrs < x <= 45 yrs)	25.0	36.0	1.0	DF508/DF508	1.0	No	Kaftrio	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d129
MSV000100923	25M18.mzXML	25M18	animal	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002767	electrospray ionization (positive)	reverse phase (C18)	25.0	18.0	Early Adulthood (18 yrs < x <= 45 yrs)	25.0	36.0	1.0	DF508/DF508	1.0	No	Kaftrio	methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d130
MSV000100923	Blank01.mzXML	Blank01	blank_analysis				2025		France	2026	Q Exactive Plus|MS:1002647	electrospray ionization (positive)	reverse phase (C18)												17	
MSV000100923	Blank02.mzXML	Blank02	blank_analysis				2025		France	2026	Q Exactive Plus|MS:1002789	electrospray ionization (positive)	reverse phase (C18)												159	
MSV000100923	Blank03.mzXML	Blank03	blank_analysis				2025		France	2026	Q Exactive Plus|MS:1002790	electrospray ionization (positive)	reverse phase (C18)												160	
MSV000100923	Blank04.mzXML	Blank04	blank_analysis				2025		France	2026	Q Exactive Plus|MS:1002791	electrospray ionization (positive)	reverse phase (C18)												161	
MSV000100923	QC01.mzXML	QC01	pool_QC	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002648	electrospray ionization (positive)	reverse phase (C18)										methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d130	18
MSV000100923	QC02.mzXML	QC02	pool_QC	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002658	electrospray ionization (positive)	reverse phase (C18)										methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d131	28
MSV000100923	QC03.mzXML	QC03	pool_QC	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002668	electrospray ionization (positive)	reverse phase (C18)										methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d132	38
MSV000100923	QC04.mzXML	QC04	pool_QC	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002678	electrospray ionization (positive)	reverse phase (C18)										methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d133	48
MSV000100923	QC05.mzXML	QC05	pool_QC	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002688	electrospray ionization (positive)	reverse phase (C18)										methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d134	58
MSV000100923	QC06.mzXML	QC06	pool_QC	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002698	electrospray ionization (positive)	reverse phase (C18)										methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d135	68
MSV000100923	QC07.mzXML	QC07	pool_QC	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002708	electrospray ionization (positive)	reverse phase (C18)										methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d136	78
MSV000100923	QC08.mzXML	QC08	pool_QC	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002718	electrospray ionization (positive)	reverse phase (C18)										methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d137	88
MSV000100923	QC09.mzXML	QC09	pool_QC	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002728	electrospray ionization (positive)	reverse phase (C18)										methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d138	98
MSV000100923	QC10.mzXML	QC10	pool_QC	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002738	electrospray ionization (positive)	reverse phase (C18)										methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d139	108
MSV000100923	QC11.mzXML	QC11	pool_QC	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002748	electrospray ionization (positive)	reverse phase (C18)										methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d140	118
MSV000100923	QC12.mzXML	QC12	pool_QC	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002758	electrospray ionization (positive)	reverse phase (C18)										methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d141	128
MSV000100923	QC13.mzXML	QC13	pool_QC	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002768	electrospray ionization (positive)	reverse phase (C18)										methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d142	138
MSV000100923	QC14.mzXML	QC14	pool_QC	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002778	electrospray ionization (positive)	reverse phase (C18)										methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d143	148
MSV000100923	QC15.mzXML	QC15	pool_QC	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002788	electrospray ionization (positive)	reverse phase (C18)										methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d144	158
MSV000100923	QCdil16_a.mzXML	QCdil16_a	pool_Qcdil	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002635	electrospray ionization (positive)	reverse phase (C18)										methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d145	5
MSV000100923	QCdil16_b.mzXML	QCdil16_b	pool_Qcdil	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002636	electrospray ionization (positive)	reverse phase (C18)										methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d146	6
MSV000100923	QCdil16_c.mzXML	QCdil16_c	pool_Qcdil	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002637	electrospray ionization (positive)	reverse phase (C18)										methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d147	7
MSV000100923	QCdil2_a.mzXML	QCdil2_a	pool_Qcdil	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002644	electrospray ionization (positive)	reverse phase (C18)										methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d148	14
MSV000100923	QCdil2_b.mzXML	QCdil2_b	pool_Qcdil	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002645	electrospray ionization (positive)	reverse phase (C18)										methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d149	15
MSV000100923	QCdil2_c.mzXML	QCdil2_c	pool_Qcdil	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002646	electrospray ionization (positive)	reverse phase (C18)										methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d150	16
MSV000100923	QCdil4_a.mzXML	QCdil4_a	pool_Qcdil	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002641	electrospray ionization (positive)	reverse phase (C18)										methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d151	11
MSV000100923	QCdil4_b.mzXML	QCdil4_b	pool_Qcdil	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002642	electrospray ionization (positive)	reverse phase (C18)										methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d152	12
MSV000100923	QCdil4_c.mzXML	QCdil4_c	pool_Qcdil	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002643	electrospray ionization (positive)	reverse phase (C18)										methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d153	13
MSV000100923	QCdil8_a.mzXML	QCdil8_a	pool_Qcdil	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002638	electrospray ionization (positive)	reverse phase (C18)										methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d154	8
MSV000100923	QCdil8_b.mzXML	QCdil8_b	pool_Qcdil	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002639	electrospray ionization (positive)	reverse phase (C18)										methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d155	9
MSV000100923	QCdil8_c.mzXML	QCdil8_c	pool_Qcdil	9606|Homo sapiens	blood plasma	chronic illness	cystic fibrosis	2025.0		France	2026	Q Exactive Plus|MS:1002640	electrospray ionization (positive)	reverse phase (C18)										methanol-water (4:1)	DL-Leucine-d10 DL-Phenyl-d5-alanine L-Tryptophan-2’,4’,5’,6’,7-d156	10
